INTERCURE LTD (INCR) Stock Analyst Earnings Estimates
NASDAQ:INCR - Nasdaq - IL0011063760 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 388.684M 76.93% | 355.553M -8.52% | 238.845M -32.82% | 404.94M 69.54% | 574M 41.75% | |
| EBITDA YoY % growth | 75.107M 60.17% | 44.863M -40.27% | -33.919M -175.61% | 47.94M 241.34% | N/A | |
| EBIT YoY % growth | 63.408M 60.53% | 31.697M -50.01% | -49.29M -255.50% | 52.635M 206.79% | 93.503M 77.64% | |
| Operating Margin | 16.31% | 8.91% | -20.64% | 13.00% | 16.29% | |
| EPS YoY % growth | N/A 199.03% | N/A -144.33% | N/A 90.70% | 0.59 1,550.00% | 1.70 187.93% |
All data in ILS
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 -304.00% | -0.02 -119.43% | -0.04 -33.33% | 0.03 106.25% | 0.08 900.00% | 0.12 700.00% | 0.18 550.00% | 0.20 566.67% |
| Revenue Q2Q % growth | 59.16M -44.28% | 69.36M -32.29% | 76.5M -26.17% | 85.68M -75.90% | 92.82M 56.90% | 95.88M 38.24% | 107.1M 40.00% | 109.14M 27.38% |
| EBITDA Q2Q % growth | 8.16M -27.97% | 10.2M -27.77% | 4.08M -48.96% | 6.12M 127.12% | 8.16M | 10.2M | 13.26M 225.00% | 15.3M 150.00% |
| EBIT Q2Q % growth | -1.911M -123.45% | 1.21M -82.59% | 4.38M 51.50% | 9.223M 125.81% | N/A | N/A | N/A | N/A |
All data in ILS
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -359.97% | -0.49 | % | |
| Q3 2023 Q2Q % growth | -119.12% | -0.03 | % | |
| Q2 2023 Q2Q % growth | 0.11 -53.21% | 0.08 | 0.02 | 28.68% |
| Q1 2023 Q2Q % growth | 0.01 -98.61% | 0.04 | -0.04 | -87.75% |
| Q4 2022 Q2Q % growth | 0.19 413.88% | 0.18 | 0.00 | 2.58% |
| Q3 2022 Q2Q % growth | 0.16 633.33% | 0.26 | -0.10 | -37.25% |
| Q2 2022 Q2Q % growth | 87.00% | 0.22 | % | |
| Q1 2022 Q2Q % growth | 0.36 | 0.18 | 0.18 | 96.08% |
| Q4 2021 Q2Q % growth | -0.06 | 0.14 | -0.20 | -142.02% |
| Q3 2021 Q2Q % growth | -0.03 | 0.15 | -0.18 | -119.61% |
| Q2 2021 Q2Q % growth | 0.12 | 0.14 | -0.02 | -15.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 355.553M 236.68% | 67.863M | 287.69M | 423.93% |
| Q3 2023 Q2Q % growth | 3.02% | 103.61M | % | |
| Q2 2023 Q2Q % growth | 102.439M 7.52% | 113.24M | -10.801M | -9.54% |
| Q1 2023 Q2Q % growth | 106.175M 21.72% | 107.61M | -1.435M | -1.33% |
| Q4 2022 Q2Q % growth | 105.606M 32.50% | 108.73M | -3.124M | -2.87% |
| Q3 2022 Q2Q % growth | 100.572M 63.01% | 108.53M | -7.958M | -7.33% |
| Q2 2022 Q2Q % growth | 95.277M 110.65% | 105.57M | -10.293M | -9.75% |
| Q1 2022 Q2Q % growth | 87.229M 163.93% | 93.024M | -5.795M | -6.23% |
| Q4 2021 Q2Q % growth | 79.701M 194.16% | 77.405M | 2.296M | 2.97% |
| Q3 2021 Q2Q % growth | 61.695M 174.24% | 59.539M | 2.156M | 3.62% |
| Q2 2021 Q2Q % growth | 45.23M 304.38% | 39.775M | 5.455M | 13.71% |
| Q1 2021 Q2Q % growth | 33.05M 676.00% | % | ||
| Q4 2020 Q2Q % growth | 27.094M 512.16% | % | ||
| Q3 2020 Q2Q % growth | 22.497M 765.94% | % | ||
| Q2 2020 Q2Q % growth | 11.185M 148.56% | % | ||
| Q1 2020 Q2Q % growth | 4.259M 147.19% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |